Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria

Infection and Immunity

Volumn 71, Issue 6, 2003, Pages 3648-3651

  Belnoue, Elodie ^a   Costa, Fabio T M ^a   Vigário, Ana M ^a   Voza, Tatiana ^a   Gonnet, Françoise ^a   Landau, Irène ^a   Van Rooijen, Nico ^b   Mack, Matthias ^c   Kuziel, William A ^d   Rénia, Laurent ^a,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; IMMUNOPATHOGENESIS; KNOCKOUT MOUSE; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; MALARIA, CEREBRAL; MESENCEPHALON; MICE; MICE, INBRED C57BL; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 0038103797     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.6.3648-3651.2003     Document Type: Article

References (29)

1. Amani, V., A. M. Vigario, E. Belnoue, M. Marussig, L. Fonseca, D. Mazier, and L. Rénia. 2000. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30:1646-1655.
2. + T cells in experimental cerebral malaria. J. Immunol. 169:6369-6375.
3. Belnoue, E., M. Kayibanda, J.-C. Deschemin, M. Viguier, M. Mack, W. A. Kuziel, and L. Renia. CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood, in press.
4. Berendt, A. R., G. D. H. Turner, and C. I. Newbold. 1994. Cerebral malaria: the sequestration hypothesis. Parasitol. Today 10:412-414.
5. Berger, O., X. Gan, C. Gujuluva, A. R. Burns, G. Sulur, M. Stins, D. Way, M. Witte, M. Weinand, J. Said, K. S. Kim, D. Taub, M. C. Graves, and M. Fiala. 1999. CXC and CC chemokine receptors on coronary and brain endothelia. Mol. Med. 5:795-805.
6. -/- mice. J. Immunol. 165:2603-2611.
7. Boring, L., J. Gosling, S. W. Chensue, S. L. Kunkel, R. V. Farese, Jr., and H. E. Broxmeyer. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Investig. 100:2552-2561.
8. Fife, B. T., G. B. Huffnagle, W. A. Kuziel, and W. J. Karpus. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:899-905.
9. Grau, G. E., C. D. Mackenzie, R. A. Carr, M. Redard, G. Pizzolato, C. Allasia, C. Cataldo, T. E. Taylor, and M. E. Molyneux. 2003. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J. Infect. Dis. 187:461-466.
10. Hearn, J., N. Rayment, D. N. Landon, D. R. Katz, and J. B. De Souza. 2000. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 68:5364-5376.
11. Hesselgesser, J., and R. Horuk. 1999. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:13-26.
12. Jennings, V. M., J. K. Actor, A. A. Lal, and R. L. Hunter. 1997. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun. 65:4883-4887.
13. Kurihara, T., G. Warr, J. Loy, and R. Bravo. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1757-1762.
14. Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94:12053-12058.
15. Lopez, A. F., M. Strath, and C. J. Sanderson. 1984. Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br. J. Haematol. 57:489-494.
16. Lou, J., R. Lucas, and G. E. Grau. 2001. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 14:810-820.
17. Mack, M., J. Cihak, C. Simonis, B. Luckow, A. E. Proudfoot, J. Plachy, H. Bruhl, M. Frink, H. J. Anders, V. Vielhauer, J. Pfistinger, M. Stangassinger, and D. Schlondorff. 2000. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166:4697-4704.
18. MacPherson, G. G., M. J. Warrell, N. J. White, S. Looareesuwan, and D. A. Warrell. 1985. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119:385-401.
19. + T cells increase during viral infection and migrate to sites of infection. Eur. J. Immunol. 30:1797-1806.
20. Neill, A. L., and N. H. Hunt. 1992. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 105:165-175.
21. Patnaik, J. K., B. S. Das, S. K. Mishra, S. Mohanty, S. K. Satpathy, and D. Mohanty. 1994. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am. J. Trop. Med. Hyg. 51:642-647.
22. Rest, J. R. 1982. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans. R. Soc. Trop. Med. Hyg. 76:410-415.
23. Sato, N., S. K. Ahuja, M. Quinones, V. Kostecki, R. L. Reddick, P. C. Melby, W. A. Kuziel, and S. S. Ahuja. 2000. CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of Th1 cell type (Th1)-inducing dendritic cells: absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192:205-243.
24. Sato, N., W. A. Kuziel, P. C. Melby, R. L. Reddick, V. Kostecki, W. Zhao, N. Maeda, S. K. Ahuja, and S. S. Ahuja. 1999. Defects in the generation of IFN-γ are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1α-, or CCR2-deficient mice. J. Immunol. 163:5519-5525.
25. Silamut, K., N. H. Phu, C. Whitty, G. D. Turner, K. Louwrier, N. T. Mai, J. A. Simpson, T. T. Hien, and N. J. White. 1999. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am. J. Pathol. 155:395-410.
26. Traynor, T. R., W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2000. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2021-2027.
27. Van Rooijen, N., A. Sanders, and T. K. van den Berg. 1996. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J. Immunol. Methods 193:93-99.
28. Vigario, A. M., E. Belnoue, A. Cumano, M. Marussig, F. Miltgen, I. Landau, D. Mazier, I. Gresser, and L. Renia. 2001. Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte. Blood 97:3966-3971.
29. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.